11-phosphorous steroid derivatives useful as progesterone receptor modulators

Details for Australian Patent Application No. 2007217094 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Sui, Zhihua; Jiang, Weiqin

Agent Shelston IP

Pub. Number AU-A-2007217094

PCT Pub. Number WO2007/098381

Priority 60/774,735 17.02.06 US

Filing date 16 February 2007

Wipo publication date 30 August 2007

International Classifications

C07J 51/00 (2006.01) Normal steroids with unmodified cyclopenta[a]hydrophenanthrene skeleton not provided for in groups

A61K 31/565 (2006.01) - not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol

A61P 5/36 (2006.01) Drugs for disorders of the endocrine system

Event Publications

4 September 2008 PCT application entered the National Phase

  PCT publication WO2007/098381 Priority application(s): WO2007/098381

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007217095-17-phosphorous steroid derivatives useful as progesterone receptor modulators

2007217092-Methods of extracting nucleic acids